Cybrid™ is the revolutionary live tumor diagnostic platform that powers Elephas’ Biopharma Service offerings. Its unique process and proprietary instruments bring a new dimension of capabilities and insights to analysis of response to oncology therapies. No platform can provide this distinct combination of capabilities:
A cloud-based portal, CybridView™ offers frictionless access to results and data from studies run through the Cybrid™ platform. Results are available within two weeks* of the study completion with dynamic visualization for analysis of multiomic assays and images.
*<20 patient samples, time from receipt of test article